Wall Street Associates’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BFA
O
TCM
CCA
BIT
Wall Street Associates's RGEN Position: Q4 2016 in Review
Wall Street Associates held its Repligen (RGEN) position steady in Q4 2016 at 20,000 shares worth $616K. The position accounts for 0.41% of the portfolio, ranked #90.
Wall Street Associates first reported a position in RGEN in Q3 2013 and has held it in 14 quarters since. The position peaked at $21.2M in Q1 2015. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2016.
- Wall Street Associates held 20,000 shares of Repligen worth $616K as of Q4 2016.
- Wall Street Associates left its Repligen share count unchanged in Q4 2016.
- Repligen made up 0.41% of Wall Street Associates's portfolio in Q4 2016, its #90 holding.
- Wall Street Associates first reported a position in Repligen in Q3 2013 and has held it in 14 quarters since.
- Wall Street Associates's Repligen position peaked at $21.2M in Q1 2015.
- 184 funds tracked by Wall St. Rank held Repligen as of Q4 2016.
Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.